During the 1990's Michigan Vascular Center (MVC) surgeons traveled abroad to learn the new technique of carotid artery stenting. This was long before FDA approval of the devices in the United States. These devices could only be used in the US in patients enrolled in a clinical trial. Michigan Vascular Research Department was created to facilitate clinical trials in our community. This was one of the very first research departments outside of a University setting.
Michigan Vascular Research Department now employs specifically educated staff to manage and operate the department, screening new trials, matching patients with appropriate trils, enrolling patients into trials, and ensuring compliance with all of the regulatory matters. Nine vascular surgeons, a nurse practitioner, a physician assistant, two clinical research coordinators and a research assistant comprise our team.
By participating in a clinical trial a patient gains access to treatments or procedures not yet available in the community. In fact, Michigan Vascular Center has taken a leadership role in bringing state-of-the-art endovascular treatments to Michigan:
Since its formation in 1998, we have participated in numerous device, drug and investigator-initiated trials. Without clinical research, medical and surgical innovations could not occur. Because our generation and generations to come rely on today’s clinical research efforts, we are committed to offering innovative and otherwise unavailable treatments to our patients.